We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+19.73%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$204B
AUM Growth
+$40.7B
Cap. Flow
+$14.4B
Cap. Flow %
7.02%
Top 10 Hldgs %
15.11%
Holding
4,579
New
569
Increased
2,381
Reduced
1,060
Closed
261

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$845M
2
TME icon
Tencent Music
TME
+$643M
3
BIDU icon
Baidu
BIDU
+$528M
4
TSLA icon
Tesla
TSLA
+$476M
5
AMZN icon
Amazon
AMZN
+$391M

Sector Composition

Rank Sector Weight
1 Technology 13.51%
2 Consumer Discretionary 9.39%
3 Healthcare 9.23%
4 Communication Services 7.28%
5 Financials 7.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NYMX
4051
DELISTED
Nymox Pharmaceutical Corp
NYMX
$103K ﹤0.01%
41,721
+11,285
+37% +$24.9K
UEC icon
4052
Uranium Energy
UEC
$5.57B
$101K ﹤0.01%
+57,154
New +$67.5K
GNK icon
4053
Genco Shipping & Trading
GNK
$1.1B
$100K ﹤0.01%
+13,559
New +$98.7K
UGP icon
4054
Ultrapar
UGP
$6.54B
$100K ﹤0.01%
22,198
IVC
4055
DELISTED
Invacare Corporation
IVC
$98K ﹤0.01%
10,901
-144
-1% -$1.2K
GSKY
4056
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
$98K ﹤0.01%
+21,209
New +$96K
DSKE
4057
DELISTED
Daseke, Inc. Common Stock
DSKE
$97K ﹤0.01%
+16,674
New +$106K
PRTK
4058
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$96K ﹤0.01%
+15,226
New +$89.6K
CMRX
4059
DELISTED
Chimerix, Inc.
CMRX
$95K ﹤0.01%
+19,572
New +$71K
CTSO icon
4060
Cytosorbents Corp
CTSO
$22.6M
$94K ﹤0.01%
+11,792
New +$98.7K
SRTY icon
4061
ProShares UltraPro Short Russell2000
SRTY
$71.9M
$94K ﹤0.01%
+271
New +$146K
NNBR icon
4062
NN Inc
NNBR
$291M
$93K ﹤0.01%
+14,265
New +$88.9K
PRPO icon
4063
Precipio
PRPO
$42.8M
$92K ﹤0.01%
+2,214
New +$97.7K
APRN
4064
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$92K ﹤0.01%
+1,376
New +$107K
SYRE icon
4065
Spyre Therapeutics
SYRE
$9.25B
$91K ﹤0.01%
+464
New +$96.2K
CNR
4066
Core Natural Resources Inc
CNR
$4.45B
$91K ﹤0.01%
+12,547
New +$65.7K
VIOT
4067
Viomi Technology
VIOT
$49.2M
$90K ﹤0.01%
+17,367
New +$100K
LTRPA
4068
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$90K ﹤0.01%
20,699
-40,232
-66% -$109K
MMX
4069
DELISTED
Maverix Metals Inc. Common Shares
MMX
$90K ﹤0.01%
+16,595
New +$86.8K
ENBL
4070
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
$85K ﹤0.01%
16,090
+1,064
+7% +$5.4K
EMWP
4071
DELISTED
Eros Media World PLC
EMWP
$84K ﹤0.01%
2,314
+1,615
+231% +$70.2K
ACTG icon
4072
Acacia Research
ACTG
$470M
$82K ﹤0.01%
+20,841
New +$74.8K
AVXL icon
4073
Anavex Life Sciences
AVXL
$310M
$81K ﹤0.01%
+15,071
New +$79.4K
LITS
4074
Lite Strategy Inc
LITS
$30.9M
$81K ﹤0.01%
+1,537
New +$88.7K
NDLS icon
4075
Noodles & Co
NDLS
$107M
$79K ﹤0.01%
+1,257
New +$77.6K

Similar funds

Credit Suisse's Q4 2020 Portfolio in Review

As of Q4 2020, Credit Suisse held 4,579 positions worth $204B, up 25% from $164B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Credit Suisse deployed $14.4B of net new capital in Q4 2020, opening 569 new positions and adding to 2,381 existing holdings. Its largest new stake was Palantir: 6,341,206 shares worth $149M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $546M trimmed.

  • Credit Suisse's largest Q4 2020 buy was Palantir: 6,341,206 shares worth $149M.
  • Credit Suisse added most to Alibaba in Q4 2020, an estimated $845M increase.
  • Credit Suisse's biggest Q4 2020 reduction was UnitedHealth, cutting an estimated $546M.
  • Credit Suisse fully exited TD Ameritrade Holding Corp in Q4 2020, selling an estimated $260M.
  • Credit Suisse's ten largest holdings make up 15% of its $204B portfolio in Q4 2020.
  • Credit Suisse opened 569 new positions and closed 261 in Q4 2020.
  • Credit Suisse's portfolio value rose 25% quarter-over-quarter to $204B.

Based on Credit Suisse's 13F filing for Q4 2020, filed 12 Feb 2021.